CYP2D6 基因型引导的阿片类镇痛药治疗接受选择性腹疝修复术的患者
CYP2D6 基因型指导的阿片类镇痛药治疗选择性腹疝修复术患者的可行性和有效性:一项试点实用试验
Pilot pragmatic trial using an implementation science approach to determine the feasibility of a CYP2D6-guided opioid prescribing for patients undergoing elective VHRs compared to usual care. Assess the efficacy (PROMIS Pain Intensity and Hernia-Related QOL) of a CYP2D6-guided opioid prescribing approach for patients undergoing elective VHRs.
研究概览
地位
条件
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Florida
-
Jacksonville、Florida、美国、32209
- University of Florida Jacksonville
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- > 18 years age undergoing a ventral hernia repair (VHR) ≥1.5 cm in diameter with mesh.
Exclusion Criteria:
- ventral hernia <1.5 cm
- primary ventral hernia repair (VHR) without a mesh
- emergency operative procedure
- receiving chronic opioid therapy (defined as use of opioids on most days for >3 months)
- allergy to opioids
- women of childbearing potential who have a positive pregnancy result as part of their standard pre-surgical workup
学习计划
研究是如何设计的?
设计细节
- 主要用途:诊断
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:CYP2D6 genotype testing-treatment
CYP2D6 genotype testing performed preoperatively with results used to guide prescribing of opioid analgesics during the postoperative period to control pain. In addition, participants will receive standard of care postoperative pain medications. |
CYP2D6 genotype testing for assessment of medication metabolism to guide prescription of postoperative pain medication |
|
有源比较器:CYP2D6 genotype testing-control
CYP2D6 genotype testing performed preoperatively, results will be delayed until after operative procedure. Participants will receive standard of care postoperative pain medication prescriptions for pain management. |
Participants will receive standard postoperative pain medications |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Determine the feasibility of a CYP2D6-guided opioid prescribing by the percentage enrolled of patients undergoing elective VHRs compared to usual care.
大体时间:6 months
|
Percentage of potential participants approached will enroll and complete study. |
6 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Assess the efficacy of a CYP2D6-guided opioid prescribing approach for patients undergoing elective VHRs.
大体时间:6 months
|
Participants may report improved post-operative pain control and quality of life. |
6 months
|
合作者和调查者
调查人员
- 首席研究员:Ruchir Puri, MD、Associate Professor
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.